Medications

Empagliflozin offers clinical benefit in heart failure

For patients hospitalized for acute heart failure, treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin produces clinical benefit, according to a study published online April 4 in Circulation ...

Cardiology

Early rhythm control key in A-fib and heart failure

(HealthDay)—For patients with atrial fibrillation and signs and symptoms of heart failure, early rhythm control (ERC) therapy reduces cardiovascular events, according to a study published online July 30 in Circulation to ...

page 6 from 27